i n f l a r x

Loading

Inflarx Logo
  • About Inflarx
    • Leadership Team
    • Board of Directors
    • Company History
  • R & D
    • Pipeline
    • Vilobelimab
    • INF904
    • IFX002
    • Complement Platform
    • Clinical Development
      • COVID-19
      • Clinical Trials
    • Publications & Posters
  • Investors
    • Press Releases
    • Events
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Meetings
    • Email alerts
  • Careers
  • The InflaRx Commitment
  • About Inflarx
    • Leadership Team
    • Board of Directors
    • Company History
  • R & D
    • Pipeline
    • Vilobelimab
    • INF904
    • IFX002
    • Complement Platform
    • Clinical Development
      • COVID-19
      • Clinical Trials
    • Publications & Posters
  • Investors
    • Press Releases
    • Events
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Meetings
    • Email alerts
  • Careers
  • The InflaRx Commitment
Impressum Privacy policy

Contact us

+49 3641 508 180

info@inflarx.de

Address

InflaRx N.V.

Winzerlaer Str. 2, 07745 Jena

Inflarx Logo
11-2024-InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update
Home Investors Press Releases InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update
Inflarx Logo

Impressum

Privacy Policy

Contact

Contact Jena

InflaRx N.V. / InflaRx GmbH 
Winzerlaer Str. 2 
07745 Jena 

+49 3641 508 180

info@inflarx.de
InflaRx on Linkedin

Contact Munich

InflaRx N.V. / InflaRx GmbH 
Fraunhoferstraße 22 
82152 Martinsried 

+49 89 414 189 78 00

info@inflarx.de

Contact Ann Arbor

InflaRx Pharmaceuticals Inc. 
600 S. Wagner Rd. 
Ann Arbor, MI 48103 

info@inflarx.de

© 2023 InflaRx All Rights Reserved.

Privacy Policy The InflaRx Commitment

You are now leaving inflarx.de.

Click "Cancel" to return to inflarx.de or "Visit Site" to proceed.

Cancel Visit Site